Covid-19 Vaccine Protocols Reveal That Trials Are Designed to Succeed
forbes.com
forbes.com
Infection prevention or preventing severe symptoms, are however part of the secondary endpoints of the trials, something that it is not mentioned in the article.
For a counter argument, see https://mobile.twitter.com/nataliexdean/status/1308474303810...
https://www.ft.com/content/e5012891-58da-4a4f-8a05-182adf3ba...
"I am a scientist, businessman, author, and philanthropist. For nearly two decades, I was a professor at Harvard Medical School and Harvard School of Public Health where I founded two academic research departments, the Division of Biochemical Pharmacology and the Division of Human Retrovirology. I am perhaps most well known for my work on cancer, HIV/AIDS, and genomics. My work now also includes efforts to improve access to high quality, affordable healthcare for people in low, middle, and high income countries alike. I am chair and president of ACCESS Health International, a nonprofit organization I founded that fosters innovative solutions to the greatest health challenges of our day. Each of my articles at Forbes.com will focus on a specific healthcare challenge and offer best practices and innovative solutions to overcome those challenges for the benefit of all."
Is this one of these ‘we can’t be sure so let’s just wait for five years’ pieces?
I also love how we’re all supposed to listen to the experts. Except you know, those experts, in this case the people who approve these protocols.
Even when the flu vaccine isn’t dialed in for that year’s strain, it still generally makes symptoms less severe.
If these vaccines turn covid-19 into a typical cold style coronavirus, that is 100% a victory.